Showing results (211-220 of 920) with videos related to

Sort By:
Pageof 92
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancerG G Steger, C Dittrich, O Schlappack, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerR M Mader, H Zilg, O Schlappack, et al.
Anti-Cancer Drugs|February 6, 2003
Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignanciesCatharina Wenzel, Robert M Mader, Guenther G Steger, et al.
Kidney International|October 1, 1991
Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin AK Derfler, M Hayde, G Heinz, et al.
Chemotherapy|January 1, 1987
Coupling of mitoxantrone to poly(I).poly(C) reduces absorption after intraperitoneal administrationH G Eichler, B Blöchl-Daum, R Mader, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 13, 2001
Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancerJ Friedl, A Stift, P Paolini, et al.
Blood|May 15, 1994
Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segmentsP Riboldi, G Gaidano, E W Schettino, et al.
Cancer Treatment Reviews|October 4, 2005
Fulvestrant ("Faslodex"): clinical experience from the Compassionate Use ProgrammeGuenther G Steger, Maya Gips, Sergio D Simon, et al.
Experimental Cell Research|September 21, 2010
Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620I K Tentes, W M Schmidt, G Krupitza, et al.
International Urology and Nephrology|December 4, 2017
Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-upF P Tillmann, M Schmitz, L C Rump, et al.
Pageof 92